Segall Bryant & Hamill’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.67M | Sell |
45,091
-8,012
| -15% | -$1.01M | 0.08% | 300 |
|
|
2025
Q1 | $5.87M | Buy |
53,103
+6,233
| +13% | +$689K | 0.09% | 288 |
|
|
2024
Q4 | $6.4M | Buy |
46,870
+10,398
| +29% | +$1.42M | 0.09% | 295 |
|
|
2024
Q3 | $4.2M | Sell |
36,472
-512
| -1% | -$59K | 0.06% | 354 |
|
|
2024
Q2 | $5.09M | Buy |
36,984
+16,908
| +84% | +$2.33M | 0.09% | 289 |
|
|
2024
Q1 | $2.77M | Buy |
+20,076
| New | +$2.77M | 0.05% | 271 |
|